An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

PURPOSE: Paclitaxel albumin (nab-paclitaxel) is a nanoparticle albumin-bound paclitaxel formulation aimed at increasing therapeutic index in metastatic breast cancer. When compared to conventional paclitaxel, nab-paclitaxel has a reported longer time to progression, higher response, lower incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzaro, Carlo, Bordonaro, Roberto, Cognetti, Francesco, Fabi, Alessandra, De Placido, Sabino, Arpino, Grazia, Marchetti, Paolo, Botticelli, Andrea, Pronzato, Paolo, Martelli, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629871/
https://www.ncbi.nlm.nih.gov/pubmed/23610525
http://dx.doi.org/10.2147/CEOR.S41850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629871/
https://www.ncbi.nlm.nih.gov/pubmed/23610525
http://dx.doi.org/10.2147/CEOR.S41850

Ejemplares similares